ScholarLens Back to search
1992•PubMedRequires access

[Nasal CPAP--treatment of choice in obstructive sleep apnea].

Karl A. Franklin, Rune Lundgren, Åke Dahlqvist, Terje Rabben, L Rosenhall

Open publisher page 6 citations

Abstract

There is no doubt about the effectiveness of nasal-CPAP (continuous positive airway pressure) in treatment on obstructive sleep apnea syndrome (OSAS), however there has been doubts about the tolerance and compliance rate. Seventy-two (88 percent) out of 82 patients evaluated for CPAP tolerated and accepted treatment for home use. Five patients did not tolerate CPAP at all, of them four were former operated with Uvulopalatopharyngoplasty. Five patients refused home CPAP therapy. According to a questionnaire 42 (91 percent) out of 46 patients with home CPAP therapy used their CPAP five to seven nights/week. We suggest CPAP as the treatment of choice at AHI greater than 20, since the treatment is highly effective and well tolerated by the patients.

About this research paper

What this paper is about

There is no doubt about the effectiveness of nasal-CPAP (continuous positive airway pressure) in treatment on obstructive sleep apnea syndrome (OSAS), however there has been doubts about the tolerance and compliance rate. Seventy-two (88 percent) out of 82 patients evaluated for CPAP tolerated and accepted treatment for home use. Five patients did not tolerate CPAP at all, of them four were former operated with Uvulopalatopharyngoplasty. Five patients refused home CPAP therapy. According to a questionnaire 42 (91 percent) out of 46 patients with home CPAP therapy used their CPAP five to seven nights/week. We suggest CPAP as the treatment of choice at AHI greater than 20, since the treatment is highly effective and well tolerated by the patients.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

There is no doubt about the effectiveness of nasal-CPAP (continuous positive airway pressure) in treatment on obstructive sleep apnea syndrome (OSAS), however there has been doubts about the tolerance and compliance rate. Seventy-two (88 percent) out of 82 patients evaluated for CPAP tolerated and accepted treatment for home use. Five patients did not tolerate CPAP at all, of them four were former operated with Uvulopalatopharyngoplasty. Five patients refused home CPAP therapy. According to a questionnaire 42 (91 percent) out of 46 patients with home CPAP therapy used their CPAP five to seven nights/week. We suggest CPAP as the treatment of choice at AHI greater than 20, since the treatment is highly effective and well tolerated by the patients.

Key concepts: Uvulopalatopharyngoplasty, Medicine, Continuous positive airway pressure, Obstructive sleep apnea, Anesthesia, Apnea, Positive pressure, Compliance (psychology)

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
[Nasal CPAP--treatment of choice in obstructive sleep apnea]. — Research Paper | ScholarLens